The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Investigational Drugs for the Treatment of Depression (Part 2): Glutamatergic, Cholinergic, Sestrin Modulators, and Other Agents
|
---|---|
Published in |
Frontiers in Pharmacology, June 2022
|
DOI | 10.3389/fphar.2022.884155 |
Pubmed ID | |
Authors |
Octavian Vasiliu |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
France | 1 | 20% |
Unknown | 4 | 80% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 80% |
Scientists | 1 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 29 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 5 | 17% |
Student > Postgraduate | 2 | 7% |
Lecturer > Senior Lecturer | 1 | 3% |
Student > Doctoral Student | 1 | 3% |
Unspecified | 1 | 3% |
Other | 4 | 14% |
Unknown | 15 | 52% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 4 | 14% |
Nursing and Health Professions | 3 | 10% |
Biochemistry, Genetics and Molecular Biology | 2 | 7% |
Unspecified | 1 | 3% |
Mathematics | 1 | 3% |
Other | 2 | 7% |
Unknown | 16 | 55% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 July 2022.
All research outputs
#14,837,421
of 24,037,100 outputs
Outputs from Frontiers in Pharmacology
#4,798
of 17,885 outputs
Outputs of similar age
#205,725
of 429,750 outputs
Outputs of similar age from Frontiers in Pharmacology
#240
of 1,197 outputs
Altmetric has tracked 24,037,100 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 17,885 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 429,750 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 1,197 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.